US Senators Looking to Make Changes to Upcoming Legislation on Generics and PBMs
April 7, 2023
US Senators Bernie Sanders (I-VT) and Bill Cassidy (R-LA) are looking to April 19th when they can start deliberating on changes to an upcoming piece of legislation about generic drugs and the pharmacy benefit manager (PBM) industry. The bipartisan effort comes after increasing public and congressional pressure on PBMs and drug prices.
According to David Lim and Katherine Ellen Foley, “Sanders, a vocal critic of large drugmakers, hasn’t said much about PBMs throughout his 32-year tenure in Congress. Cassidy is interested in expanding access to generic drugs, which are cheaper than their brand-name counterparts. He’s also been critical of PBMs and talked about the need for industry transparency.”
To read more, click here.
(Source: Politico, April 7th, 2023)
